The pluripotent stem cells have a self-renewal ability and can be differentiated into theoretically all of cell types. The induced pluripotent stem (iPS) cells overcame the ethical problems of the human embryonic stem (ES) cell, and enable pathologic analysis of intractable diseases and drug discovery. The in vitro disease model using disease-specific iPS cells enables repeated analyses of human cells without influence of environment factors. Even though autoimmune diseases are polygenic diseases, autoimmune disease-specific iPS cells are thought to be a promising tool for analyzing the pathogenesis of the diseases and drug discovery in future.
CITATION STYLE
Natsumoto, B., Shoda, H., Fujio, K., Otsu, M., & Yamamoto, K. (2017). Investigation of the pathogenesis of autoimmune diseases by IPS cells. Japanese Journal of Clinical Immunology, 40(1), 48–53. https://doi.org/10.2177/jsci.40.48
Mendeley helps you to discover research relevant for your work.